AMPK/NLRP3炎性小体轴在复发性流产的治疗靶点及策略

Therapeutic targets and Strategies of AMPK / NLRP3 inflammatory body axis in recurrent abortion

ES评分 0

DOI 10.12208/j.ijcr.20220160
刊名
International Journal of Clinical Research
年,卷(期) 2022, 6(4)
作者
作者单位

重庆南川区人民医院 重庆 ;

摘要
分析AMPK/NLRP3炎性小体轴在复发性流产的治疗靶点及策略。方法 将2021-03至2022-02在我院诊治的43例复发性流产患者,列为研究组;另选择同时间内来我院治疗的43例单次流产后正常妊娠者,纳入对照组。两组均接受AMPK/NLRP3炎性小体轴、白细胞介素-1β(IL-1β)、白细胞介素-18(IL-18)、Th17/Treg、Th1/Th2检测,对比两组的检测结果。结果 研究组体内的AMPK/NLRP3炎性小体轴表达率显著高于对照组(P<0.05)。在IL-1β、IL-18、Th17/Treg及Th1/Th2细胞上,研究组高于对照组(P<0.05)。结论 AMPK/NLRP3炎性小体轴在复发性流产患者体内的表达率极高,可作为复发性流产的治疗靶点。
Abstract
Objective: To analyze the therapeutic targets and Strategies of AMPK / NLRP3 inflammatory body axis in recurrent abortion. Methods: 43 patients with recurrent abortion treated in our hospital from March 2021 to February 2022 were included in the study group; In addition, 43 cases of normal pregnancy after single Abortion Treated in our hospital at the same time were included in the control group. Both groups received AMPK / NLRP3 inflammatory body axis and interleukin-1 β (IL-1 β), Interleukin-18 (IL-18), Th17 / Treg and Th1 / Th2 were detected, and the test results of the two groups were compared. Results: the expression rate of AMPK / NLRP3 inflammatory body axis in the study group was significantly higher than that in the control group (P < 0.05). In IL-1 β, IL-18, Th17 / Treg and Th1 / Th2 cells in the study group were higher than those in the control group (P < 0.05). Conclusion: the expression rate of AMPK / NLRP3 inflammatory body axis in patients with recurrent abortion is very high, which can be used as a therapeutic target for recurrent abortion.
关键词
AMPK/NLRP3炎性小体轴;复发性流产;靶点治疗;策略
KeyWord
AMPK / NLRP3 Inflammatory Body Axis; Recurrent Abortion; Targeted Therapy; Strategy
基金项目
页码 72-74
  • 参考文献
  • 相关文献
  • 引用本文

陈琳,冯强,程焱*. AMPK/NLRP3炎性小体轴在复发性流产的治疗靶点及策略 [J]. 国际临床研究杂志. 2022; 6; (4). 72 - 74.

  • 文献评论

相关学者

相关机构